Brief: Gracell Biotechnologies Inc Says Newly Established Research Facility, Innovation Center, Is Scheduled To Open In San Diego, California, During Q1 Of 2022
12/01/2022 13:37
Jan 12 (Reuters) - Gracell Biotechnologies Inc GRCL.O :
* GRACELL BIOTECHNOLOGIES INC - NEWLY ESTABLISHED RESEARCH
FACILITY, INNOVATION CENTER, IS SCHEDULED TO OPEN IN SAN DIEGO,
CALIFORNIA, DURING Q1 OF 2022
Source text for Eikon: ID:nPn4Q7lMSa
Further company coverage: GRCL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gracell Biotechnologies
See all newsBrief: Gracell Biotechnologies Announces Shareholders’ Approval Of Merger Agreement
Brief: Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
Newscasts - UK Day Ahead: European shares start last week of 2023 on strong footing
Live Markets: European futures rise after holiday break
Press Digest: British Business - Dec 27